The chipmaker lost $11 billion last quarter on paper. The math underneath points somewhere very different.
Collegium Pharma (COLL) pivots to a CNS/ADHD growth platform via AZSTARYS, targeting 2026 revenue/EBITDA upside; shares look ...
Hosted on MSN
Invesco rolls out four fixed income ETFs
Invesco (IVZ) has rolled out four fixed-income ETFs designed to help investors “address some of the current investment challenges, including persistent interest‑rate uncertainty, the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results